Janssen Research and Development has confirmed that it has allocated $5.4 million (£3.4 million) in a research sponsorship to further a new investigative project into multiple sclerosis.
The move aims to accelerate treatments for the disease and expands the company's Healthy Minds clinical research, which hopes to increase understanding of neurologic and brain disorders.
As a result of the sponsorship, the Marin Community Federation's multiple sclerosis fund will establish an alliance or private and public collaborators, who will share knowledge on the condition.
Husseini K Manji, global therapeutic area head for neuroscience at Janssen Research & Development, said: "Our aim is to bring together researchers and data to foster the development of new, transformational medicines and treatment paradigms to solve mysteries of the brain and central nervous system."
The company's new sponsorship comes after it submitted an application to the US Food and Drug Administration in an effort to obtain approval for the investigational drug bedaquiline.